Our results are closer to the ones obtained in a recently
published study performed with the UK-based primary care
database THIN, in which the authors found a RR associated
with NSAIDs of 2.79 (95%CI: 2.44–3.21) [14]. Interestingly,
this RR is lower than the one detected by the same
authors also in the UK in an earlier time period (RR03.7;
95%CI: 3.1–4.3) [8], which suggests that the burden of
NSAIDs-induced UGIB could also be decreasing in other
countries.